ImageneBio, Inc. (IMA) Return on equity 2021–2025
ImageneBio, Inc. (IMA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-34.1%FY2025 · since FY2021: -16.4% → -34.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -34.1% | — |
| FY2022 | -46.8% | -30.4 pp |
| FY2021 | -16.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice